Teva says it has now “fully resolved” a nationwide US settlement over its long-running opioids litigation by agreeing terms with “all 50 states and 99% of litigating subdivisions,” including a $193m settlement with Nevada which had been holding out ahead of a planned trial.
Having previously settled with a series of individual states – including Texas, Florida, Louisiana, Rhode Island, West Virginia, San Francisco and New York. (Also see "Teva’s New York Opioid Liability Climbs To $523m With Settlement Deal" - Generics Bulletin, 4 November, 2022